Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NA-704
- Development stage
- Unknown
- Lead developer
- Biomed
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
NA-704 (Vineurocin) is a small molecule therapeutic being developed by Biomed Industries and its subsidiary NeuroActiva for the treatment of neurodegenerative diseases, primarily Amyotrophic Lateral Sclerosis (ALS). The drug is designed to stimulate neurogenesis and provide neuroprotection by regulating nerve cell growth, development, and DNA synthesis. It has demonstrated the ability to cross the blood-brain barrier and is reported to reduce muscular spasticity. NA-704 is administered intravenously once weekly, often utilizing the MICROS Controlled Release Infusion System, an FDA-approved device that allows for controlled release administration in both hospital and home care settings. It is currently in Phase 2B clinical trials for ALS.
- Brand names
- Vineurocin
Beyond the preview
Go deeper on NA-704.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NA-704.